Target intelligence / Profile preview

MAGE family member C2 (MAGEC2)

Target
MAGEC2
Molecular classification
Cancer/testis antigen, Protein-coding gene
01

Overview

MAGEC2 is a cancer/testis antigen expressed in various tumors but minimally in normal tissues (except testis). Its expression is linked to oncogenic activation and poor prognosis, making it an attractive target for cancer immunotherapy, particularly TCR-based therapies. It is involved in tumorigenesis by interfering with tumor suppressor pathways.

Other names
CT10HCA587MAGEE1Melanoma-associated antigen C2
02

Mechanism of action

TCR gene therapy targeting specific epitopes

03

Biological functions

OncogenesisRegulation of p53 transactivationInteraction with TRIM28Immune response
04

Disease associations

CancerMelanomaHepatocellular carcinomaHead and neck squamous cell carcinoma
05

Safety considerations

Potential for off-target effects in normal tissues expressing MAGE family membersRisk of autoimmunity due to T-cell cross-reactivity
06

Biomarkers

MAGEC2 expression in tumorsALK(336–344)/HLA-A2LLF(191–200)/HLA-A2SES(307–315)/HLA-B44

Beyond the preview

Go deeper on MAGE family member C2 (MAGEC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAGE family member C2 (MAGEC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call